The most interesting article in the last few weeks' reading describes the treatment of breast cancer with anastrazole with or without a PI3K pathway inhibitor.
The most interesting article in the last few weeks' reading describes the treatment of breast cancer with anastrazole with or without a PI3K pathway inhibitor.